Clemex Discloses Third Quarter Results

Symbol:  CXG.A-CDNX

www.clemex.com

Shares Outstanding:  30,999,810

MONTREAL, March 19, 2013 /CNW Telbec/ – Clemex Technologies Inc. (TSXV:
CXG.A), designer and manufacturer of Image Analysis systems and
software for microscopy applications, announces its financial results
for the third Quarter of FY2013 ending January 31(st), 2013. For this third Quarter, sales reached $1,494,978 a decrease of
8.5% compared to the same period last year. The Corporation ends this
quarter with a Net Result of $17,669 compared to a Net Result of
$66,341 posted last year. For the nine month period of FY2013, sales
reached $4,370,581 compared to $4,289,280 last year while the Company
posted a Net Result of $74,451 compared to a Net Result of $32,098 for
the same period last year.

During this third Quarter, the Corporation made several sales to clients
in the manufacturing sector in North America: CamCraft, IL, Exxon
Mobil, TX, Charter Automotive, WI, LM Enterprises, FL, Federal Mogul,
MI and Blue Water, IL.  As for the International side, the Corporation
made major sales to West Pharma, Germany and to its Distributor in
Turkey, Karfo-Endustriyel.

FINANCIAL HIGHLIGHTS   

                                       Quarter              Nine Months

             Fiscal Years       2013        2012        2013        2012

                                   $           $           $           $

    Sales                    1,494,978   1,634,138   4,370,581   4,289,280

    Gross Margin               841,939     904,295   2,383,872   2,333,805

    Gross Margin %               56.3%       55.3%       54.5%       54.4%

    Total Operating Expenses   788,170     795,454   2,200,321   2,194,207

    Income Taxes                36,100      42,500     109,100     107,500

    Net Result attributable
    to Clemex Technologies
    Inc.                        17,669      66,341      74,451      32,098

    Global Result per share
    (basic and diluted)          0.001       0.003       0.002       0.001

Clement Forget, President and CEO of Clemex Technologies Inc. declared:
“Despite the fact that sales for this Quarter are slightly lower than
for the same period last year, we are pleased with the results of this
third Quarter of 2013. The manufacturing sector in the USA is still
unstable despite the automotive sector regain of activity and we have
difficulties to conclude sales in other sectors such as the Aerospace
and Pharmaceutical industries. On the positive side, despite the
reduced sales, an improvement in our Gross Margin allowed us to
generate a Net Profit of $17,669.

Mr. Forget continues “With regards to our Hematology project, we have
implemented two instruments in specialized laboratories for validation
over the last three months; one of them being a Hospital. A third
instrument is to be implemented in another hospital at the end of this
month.  Finally, we are pleased to announce that the Company signed a
commitment to buy a parcel of land of 10 000 square meters in the
Technological Park in Saint-Bruno-de-Montarville for an office building
to be built in 2014.”

About Clemex Technologies, Inc.

Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research
microscopy laboratories. Clemex’ customer base spans over many
countries in America, Europe, Asia and encompasses major Research and
Development Centers, prestigious Universities and large manufacturing
industries in various fields including healthcare, automotive,
aerospace, raw materials manufacturing, pharmaceuticals, mining and
other sectors.

The CDNX has not reviewed and does not accept responsibility for the
adequacy and accuracy of this press release.

SOURCE CLEMEX TECHNOLOGIES INC.